SRBCF
Price:
$0.0399
Market Cap:
$14.46M
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. Sirona Biochem Corp. has a research collaboration agreement with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop antiviral library of compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 an...[Read more]
Industry
Biotechnology
IPO Date
2013-02-12
Stock Exchange
PNK
Ticker
SRBCF
According to Sirona Biochem Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -3.99. This represents a change of -46.32% compared to the average of -7.43 of the last 4 quarters.
The mean historical PE Ratio of Sirona Biochem Corp. over the last ten years is -10.73. The current -3.99 PE Ratio has changed 3.62% with respect to the historical average. Over the past ten years (40 quarters), SRBCF's PE Ratio was at its highest in in the July 2018 quarter at 38.03. The PE Ratio was at its lowest in in the January 2018 quarter at -50.01.
Average
-10.73
Median
-8.90
Minimum
-19.56
Maximum
-3.76
Discovering the peaks and valleys of Sirona Biochem Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.48%
Maximum Annual PE Ratio = -3.76
Minimum Annual Increase = -57.17%
Minimum Annual PE Ratio = -19.56
Year | PE Ratio | Change |
---|---|---|
2023 | -7.36 | -11.43% |
2022 | -8.31 | -57.17% |
2021 | -19.40 | 42.80% |
2020 | -13.58 | -30.57% |
2019 | -19.56 | 47.16% |
2018 | -13.29 | 162.48% |
2017 | -5.06 | -46.62% |
2016 | -9.49 | 26.39% |
2015 | -7.51 | 99.43% |
2014 | -3.76 | -18.37% |
The current PE Ratio of Sirona Biochem Corp. (SRBCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.69
5-year avg
-13.64
10-year avg
-10.73
Sirona Biochem Corp.’s PE Ratio is less than Adynxx, Inc. (0), less than NLS Pharmaceutics AG (0), greater than Ascletis Pharma Inc. (-90.25), greater than Surrozen, Inc. (-57.73), less than Bolt Biotherapeutics, Inc. (-0.70), less than Larimar Therapeutics, Inc. (-0.38), greater than Keros Therapeutics, Inc. (-7.46), greater than Kezar Life Sciences, Inc. (-12.88), greater than Coya Therapeutics, Inc. (-5.24), greater than Cue Biopharma, Inc. (-10.12), less than Lantern Pharma Inc. (-1.59), less than Fennec Pharmaceuticals Inc. (-1.99), less than Eliem Therapeutics, Inc. (47.68), less than SciSparc Ltd. (-2.42), less than OncoSec Medical Incorporated (-0.02), less than Virax Biolabs Group Limited (-0.05), less than Hillstream BioPharma, Inc. (-0.68), less than ZyVersa Therapeutics, Inc. (-0.00), less than Eiger BioPharmaceuticals, Inc. (-0.07), less than Spruce Biosciences, Inc. (-0.03), less than Werewolf Therapeutics, Inc. (-0.51), less than Unicycive Therapeutics, Inc. (-1.83), less than Fusion Pharmaceuticals Inc. (-0.62), greater than null (-17.31),
Company | PE Ratio | Market cap |
---|---|---|
0 | $581.00 | |
0 | $7.33M | |
-90.25 | $154.30M | |
-57.73 | $38.09M | |
-0.70 | $25.56M | |
-0.38 | $483.02M | |
-7.46 | $2.25B | |
-12.88 | $51.73M | |
-5.24 | $104.27M | |
-10.12 | $89.71M | |
-1.59 | $35.31M | |
-1.99 | $127.22M | |
47.68 | $342.68M | |
-2.42 | $2.31M | |
-0.02 | $1.65M | |
-0.05 | $8.86M | |
-0.68 | $4.17M | |
-0.00 | $1.96M | |
-0.07 | $2.55M | |
-0.03 | $22.10M | |
-0.51 | $98.77M | |
-1.83 | $45.28M | |
-0.62 | $1.83B | |
-17.31 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sirona Biochem Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sirona Biochem Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sirona Biochem Corp.'s PE Ratio?
How is the PE Ratio calculated for Sirona Biochem Corp. (SRBCF)?
What is the highest PE Ratio for Sirona Biochem Corp. (SRBCF)?
What is the 3-year average PE Ratio for Sirona Biochem Corp. (SRBCF)?
What is the 5-year average PE Ratio for Sirona Biochem Corp. (SRBCF)?
How does the current PE Ratio for Sirona Biochem Corp. (SRBCF) compare to its historical average?